Fundamental Analysis
20 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -58.7% | -82.1% | 0 / 3 | +207.2% | -10.91 pp | -3.15 pp | +2.2% | 0.93 | 18.84 | 310 | +207,2% | 1,5 | −58,7% | 18.84 | 6.60 | +185,5% |
| Pts | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 20.700 (close price on 2026-10-15)EPS (TTM): 1.099
Financial charts
1.Revenue & growth
VND bn310Q2/26
1.Revenue & growth
VND bn310Q2/26
2.Profit & growth
VND bn1,52Q2/26
3.Profit mix (Penman)
VND bn5,97Q2/26
4.Margins & cost structure
%7.6%Q2/26
5.Returns & cash cycle
% · days5.3%Q2/26
6.Earnings quality & cash
VND bn237Q2/26
7.Asset structure
VND bn608Q2/26
8.Funding & debt health
VND bn · times608Q2/26
9.Revenue backlog
VND bn0,66Q2/26
10.Valuation
times · %18,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %299Q2/26
Adjusted EPS growth, latest quarter
-58.7%
Average adjusted EPS growth, 3 quarters
-82.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26